Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
170.20    -0.20 (-0.12%)
Bid:
169.60
Ask:
170.40
Spread: 0.80 (0.472%)
Market Cap: £208.86m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

Directorate change

26 Nov 2025 07:00

RNS Number : 9812I
SThree plc
26 November 2025
 

 

 

26 November 2025

 

SThree plc

 

Non-Executive Directorate Changes

 

SThree plc, the global STEM workforce consultancy, is pleased to announce the appointment of Rosie Shapland as an Independent Non-Executive Director with effect from 27 November 2025.

 

Rosie, who was selected as part of the Board's ongoing succession planning, is a proven non-executive director with considerable experience chairing audit and risk committees for UK-listed businesses. Rosie is a Chartered Accountant and former audit partner at PwC, with over 30 years of audit experience across multiple sectors. She brings extensive knowledge of accounting and financial reporting, risk management and governance.

 

Rosie is the Senior Independent Director and Chair of the Audit Committee at Foxtons Group PLC and Workspace Group PLC, and a Non-Executive Director and Chair of the Audit Committee of Paypoint plc.

 

On joining SThree's Board, Rosie will also be appointed as a member of the Audit and Risk, Nominations and Remuneration Committees.

 

SThree further announces that Elaine O'Donnell, who has served as a Director and Chair of the Audit and Risk Committee since October 2022, has announced her intention to resign as a director of the Company with effect from 31 December 2025. Elaine is stepping down as a consequence of additional time requirements arising from her other business commitments.

 

Following Elaine's resignation, Rosie will succeed Elaine as Chair of the Audit and Risk Committee; Rosie and Elaine will work together closely in the lead up, to ensure a smooth transition.

 

James Bilefield, Chair, commented

 

"I am delighted to welcome Rosie to SThree and the Board. Her extensive experience in audit and risk, and deep governance understanding, will serve to strengthen the Board as it continues to execute its strategy.

 

"On behalf of the Board, I would like to thank Elaine for her significant contribution to the Company and the commitment and insight she has given to her leadership of the Audit and Risk Committee. Whilst we are sorry to see her leave, we wish her every success in the future."

 

There is no further information to be disclosed pursuant to Listing Rule 6.4.8.

 

Enquiries

SThree plc

Timo Lehne, CEO

via Alma

Andrew Beach, CFO

Keren Oser, Investor Relations Director

Charlie Hildesley, Investor Relations Manager 

 

Alma Strategic Communications

+44 20 3405 0205

 

SThree@almastrategic.com  

Rebecca Sanders-Hewett  

Hilary Buchanan

Sam Modlin

Will Ellis Hancock 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPGUWGUPAGMA
Date   Source Headline
5th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20265:25 pmRNSHolding(s) in Company
1st Jun 202612:29 pmRNSTotal Voting Rights
29th May 20267:00 amRNSTransaction in Own Shares
26th May 20264:00 pmRNSHolding(s) in Company
26th May 20269:30 amRNSHolding(s) in Company
22nd May 20263:00 pmRNSDirector/PDMR Shareholding
22nd May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
12th May 20265:16 pmRNSDirector/PDMR Shareholding
8th May 20267:00 amRNSTransaction in Own Shares
1st May 20269:51 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20263:30 pmRNSHolding(s) in Company
29th Apr 202612:20 pmRNSResult of AGM
24th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 202610:35 amRNSHolding(s) in Company
14th Apr 202610:29 amRNSHolding(s) in Company
13th Apr 20264:45 pmRNSDirector/PDMR Shareholding
13th Apr 20263:38 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20264:14 pmRNSHolding(s) in Company
7th Apr 20269:30 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202612:18 pmRNSTotal Voting Rights
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20262:37 pmRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20263:37 pmRNSPurchase of shares into the EBT
17th Mar 20269:50 amRNSHolding(s) in Company
17th Mar 20267:01 amRNSCFO departure and succession plan
17th Mar 20267:01 amRNSCFO departure and succession plan
17th Mar 20267:00 amRNSFY26 Q1 Trading Update
17th Mar 20267:00 amRNSFY26 Q1 Trading Update
13th Mar 20263:30 pmRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20264:12 pmRNSDirector/PDMR Shareholding
10th Mar 20264:12 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 202611:00 amRNSAnnual Financial Report
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20264:37 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.